Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Fischer Laurent Create: Alert

All | News | Filings
Date FiledTypeDescription
03/17/2023 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 41,239 shares @ $0.7816, valued at $32.2k
09/21/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 41,082 shares @ $1.0696, valued at $43.9k
09/16/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 675,022 options to buy @ $1.09, valued at $735.8k
Granted 584,978 options to buy @ $1.09, valued at $637.6k
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 25,000 shares @ $1.112, valued at $27.8k
03/17/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 630,000 options to buy @ $1.29, valued at $812.7k
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $16.88, valued at $287k
03/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2021 4 Fischer Laurent (CEO and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 8,600 shares @ $11.5338, valued at $99.2k
08/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Fischer Laurent (CEO and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 1,200,000 options to buy @ $23.7, valued at $28.4M
06/17/2020 3 Fischer Laurent (CEO and Director) has filed a Form 3 on Adverum Biotechnologies, Inc.
06/15/2020 4 Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Granted 17,000 options to buy @ $16.71, valued at $284.1k
03/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/18/2019 4 Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Bought 452 shares @ $9.47, valued at $4.3k
Bought 1,648 shares @ $9.366, valued at $15.4k
09/10/2019 4 Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns: Bought 1,720 shares @ $10.7147, valued at $18.4k
Bought 1,670 shares @ $10.54, valued at $17.6k
Bought 300 shares @ $11.3, valued at $3.4k
Bought 960 shares @ $10.2932, valued at $9.9k
07/17/2019 3 Fischer Laurent (Director) has filed a Form 3 on Mirum Pharmaceuticals, Inc.
05/20/2019 4 Fischer Laurent (Director) has filed a Form 4 on CTI BIOPHARMA CORP
Txns: Granted 120,000 options to buy @ $0.8411, valued at $100.9k
05/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
11/03/2016 4 Fischer Laurent (CEO) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Disposed/sold 4,332 options to buy @ $2.96, valued at $12.8k
Disposed/sold 4,332 options to buy @ $3.14, valued at $13.6k
Disposed/sold 53,616 options to buy @ $3.14, valued at $168.4k
Disposed/sold 16,416 options to buy @ $3.14, valued at $51.5k
Disposed/sold 83,324 options to buy @ $4.81, valued at $400.8k
Disposed/sold 503,882 options to buy @ $4.81, valued at $2.4M
Disposed/sold 105,000 options to buy @ $14, valued at $1.5M
Disposed/sold 258,000 options to buy @ $7.91, valued at $2M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy